Advertisement

Topics

Inogen, Inc (INGN) Expected to Post Quarterly Sales of $59.17 Million

02:13 EDT 29 Jun 2017 | Topix

Equities analysts predict that Inogen, Inc will announce $59.17 million in sales for the current quarter, according to Zacks Investment Research . Three analysts have provided estimates for Inogen's earnings, with the lowest sales estimate coming in at $56.92 million and the highest estimate coming in at $60.61 million.

Original Article: Inogen, Inc (INGN) Expected to Post Quarterly Sales of $59.17 Million

NEXT ARTICLE

More From BioPortfolio on "Inogen, Inc (INGN) Expected to Post Quarterly Sales of $59.17 Million"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...